Term
|
Definition
|
|
Term
|
Definition
| express p53 in tumor cells |
|
|
Term
|
Definition
| antagonist of CD2 receptor |
|
|
Term
|
Definition
|
|
Term
|
Definition
| block tumor vascularization |
|
|
Term
|
Definition
| irradiate malignant B cells |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| block EGF stimulation of tumor growth |
|
|
Term
|
Definition
| block tumor folate uptake |
|
|
Term
|
Definition
| suppress HER2 positive tumors |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| block retinal blood vessel growth |
|
|
Term
|
Definition
| block retinal blood vessel growth |
|
|
Term
|
Definition
|
|
Term
| Mylotarg/gemtuzumab ozogamicin |
|
Definition
| deliver toxin to AML cells |
|
|
Term
| Ontak/denileukin diftitox |
|
Definition
| deliver toxin to malignant T cells |
|
|
Term
|
Definition
|
|
Term
|
Definition
| inhibit osteoclast activity |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| suppress malignant B cells |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| prevent complement activation |
|
|
Term
|
Definition
|
|
Term
|
Definition
| stimulate anticancer immunity |
|
|
Term
| Symlin/pramlintide acetate |
|
Definition
|
|
Term
|
Definition
| stimulate antiviral immunity |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| stimulate antiviral immunity |
|
|
Term
|
Definition
| stimulate abticancer immunity |
|
|
Term
|
Definition
|
|
Term
| Uplyso/taliglucerase alpha |
|
Definition
|
|
Term
|
Definition
| block EGF stimulation of tumor growth |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Zevalin/Ibritumomab tiuxetan |
|
Definition
| irradiate malignant B cells |
|
|